A novel tetracationic phthalocyanine as a potential skin phototherapeutic agent

Experimental Dermatology

Volumn 14, Issue 9, 2005, Pages 675-683

  Fabris, Clara ^a   Soncin, Marina ^a   Mazzon, Emanuela ^b   Calzavara Pinton, Piergiacomo ^b   Lia, Fantetti ^a   Giacomo, Chiti ^a   Dei, Donata ^a   Tampucci, Silvia ^a   Roncucci, Gabrio ^a   Jori, Giulio ^c  

^a Molteni Farmaceutici   (Italy)

^b Azienda Spedali Civili Brescia ^*  (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cutaneous diseases; Minimal phototoxic dose; Photodynamic therapy; Photosensitization; Pthalocyanines; Singlet oxygen

Indexed keywords

1(4),8(11),15(18),22(25) TETRAKIS 3 (N,N,N TRIMETHYLAMMONIUM)PHENOXYPHTHALOCYANINATO ZINC; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; RLP 068; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DERMIS; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; EPIDERMIS; FEMALE; IRRADIATION; MOUSE; MOUSE STRAIN; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PHOTOTOXICITY; RED LIGHT; SKIN DISEASE;

ANIMALS; BIOPSY; CATIONS; DERMATOLOGIC AGENTS; DIFFUSION; EPIDERMIS; FEMALE; GELS; INDOLES; LIGHT; MICE; MICE, INBRED BALB C; MICE, INBRED HRS; MICROSCOPY, CONFOCAL; MODELS, CHEMICAL; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; RADIATION-SENSITIZING AGENTS; SKIN; TIME FACTORS; ZINC;

EID: 23844526909     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00339.x     Document Type: Article

References (30)

1. Henderson B W, Dougherty T J. How does photodynamic therapy work? Photochem Photobiol 1992: 55: 145-157.
2. Dougherty T J, Cooper M T, Mang T S. Cutaneous phototoxic occurrences in patients receiving photofrin. Lasers Surg Med 1990: 10: 485-488.
3. Calzavara-Pinton P, Szeimies R M, Ortel B, eds. Photodynamic Therapy and Fluorescence Diagnosis in Dermatology. Amsterdam, The Netherlands. Elsevier Science, 2001.
4. Calzavara-Pinton P G. Repetitive photodynamic therapy with topical 5-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 1995: 29: 53-57.
5. Szeimies R-M, Radakovic S, Calzavara-Pinton P G et al. A prospective, randomized study comparing photodynamic therapy with Metvix®, to cryotherapy in actinic keratoses. J Eur Acad Dermatol Venereol 2000: 14 (Suppl. 1): 235.
6. Van Lier J E, Spikes J D. The chemistry, photophysics and photosensitizing properties of phthalocyanines. In: Bock G, Harnett S, eds. Photosensitizing Compounds. Their Chemistry, Biology and Clinical Use. London, UK. Ciba Foundation Symposium, 1989: 17-26.
7. Wilson B C, Jeeves W P, Lowe D M, Adam G. Light propagation in animal tissue in the wavelength range 375-825 nanometers. In: Doiron D R, Gomer C J, Alan R, eds. Porphyrin Localization and Treatment of Tumours. New York: Liss Inc., 1984: 115-132.
8. Dougherty T J, Gomer C J, Henderson B W et al. Photodynamic therapy. J Natl Cancer Inst 1998: 90: 889-905.
9. Ben Hur E, Moor A C, Margolis-Nunno H, Gottlieb P, Zuk M M, Lustigman S. The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine. Transfus Med Rev 1996: 10: 15-22.
10. Visonà A, Angelini A, Gobbo S et al. Local photodynamic therapy with Zn (II)-phthalocyanine in an experimental model of intimal hyperplasia. J Photochem Photobiol B 2000: 57: 94-101.
11. Minnock A, Vernon D I, Schofield J, Griffiths J, Parish J H, Brown S T. Photoinactivation of bacteria. Use of a cationic water-soluble zinc-phthalocyanine to photo-inactivate both Gram-negative and Gram-positive bacteria. J Photochem Photobiol B 1996: 32: 159-164.
12. De Filippis M P, Dei D, Fantetti L, Roncucci G. Synthesis of a new water soluble octa cationic phthalocyanine derivative for PDT. Tetrahedron Lett 2000: 41: 9143-9147.
13. Soncin M, Fabris C, Busetti A et al. Approaches to selectivity in the Zn (II)-phthalocyanine photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem Photobiol Sci 2002: 1: 815-819.
14. Roncucci G, Dei D, De Filippis M P et al. Zn-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents. US Patent 1999: 5965598.
15. Valduga G, Reddi E, Jori G. Spectroscopic studies on Zn (II)-phthalocyanine in homogeneous and microheterogeneous sytems. J Inorg Biochem 1987: 29: 59-65.
16. Reddi E, Lambert C R Jori G, Rodgers M A. Photokinetic and photophysical measurements of the sensitized photooxidation of the tryptophyl residue in N-acetyl tryptophanamide and in human serum albumin. Photochem Photobiol 1987: 45: 345-351.
17. Foote C S. Photosensitized oxidation and singlet oxygen: consequences in biological systems. In: Pryor W A, ed. Free Radicals in Biology. Vol. 2. New York: Academic Press, 1976: 85-133.
18. Gross E, Ehrenberg B, Johnson F. Singlet oxygen generation by porphyrins and the kinetics of 9,10-dimethyl-amthracene photosensitization in liposomes. Photochem Photobiol 1993: 57: 808-813.
19. Reddi E, Zhou C, Menegaldo E, Jori G. Liposome or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990: 61: 407-411.
20. Jori G, Spikes J D. Photobiochemistry of porphyrins. In: Smith K C, ed. Topics in Photomedicine., New York: Plenum Press, 1984: 154-161.
21. Jori G. Tumour photo sensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B 1996: 36: 87-93.
22. Segalla A, Milanesi C, Jori G, Capraro H G, Isele U, Schieweck K. CGP55398, a liposomal Zn (II)-phthalocyanine: a new potential agent for photodynamic therapy of tumours. Br J Cancer 1994: 69: 817-825.
23. Moser F H, Thomas A L. The Phthalocyanines. Boca Raton, Florida: CRC Press,Inc., 1983.
24. Wilson B D, Mang T. Photodinamic therapy for cutaneous malignancies. Clin Dermatol 1995: 13: 94-96.
25. Moan J. Properties for optimal PDT sensitizers. Photochem Photobiol B 1990: 5: 521-524.
26. Svaasand L O, Martinelli E, Gomer C G, Profio A E. Optical characteristics of intraocular tumours in the visible and near-infrared. In: Dougherty T J, Katzir A, eds. Photodynamic Therapy: Mechanisms II. Vol. 1203. Bellinham, Washington: SPIE, 1990: 2-21.
27. Ruck A, Beck G, Bachor R, Akgun N, Gschwend M H, Steiner R. Dynamic fluorescence changes during photodynamic therapy in vivo and in vitro of hydrophilic A1 (III) phthalocyanine tetrasulphonate and lipophilic Zn (II) phthalocyanine administered in liposomes. J Photochem Photobiol B 1996: 36: 127-133.
28. Jori G, Reddi E. The role of lipoproteins in the delivery of tumour-targeting photosensitizers. Int J Biochem 1993: 25: 1369-1375.
29. Jori G. Photodynamic therapy: basic and preclinical aspects. In: Horspool W, Lenci F, eds. Organic Photochemistry and Photobiology. Boca Raton, Florida: CRC Press, 2004: 146-151.
30. Sidoroff A. Topical sensitization - oncologic indications - actinic keratoses. In: Calzavara-Pinton P, Szeimies R M, Ortel B, eds. Photodynamic Therapy and Fluorescence Diagnosis in Dermatology. Amsterdam, The Netherlands. Elsevier Science, 2001: 199-216.